HomeMNMD • NASDAQ
add
Mind Medicine (MindMed) Inc
Previous close
$12.10
Day range
$12.19 - $12.80
Year range
$4.70 - $14.43
Market cap
1.25B USD
Avg Volume
2.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 45.67M | 84.21% |
Net income | -67.26M | -391.56% |
Net profit margin | — | — |
Earnings per share | -0.78 | -333.33% |
EBITDA | -45.66M | -84.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 209.07M | -29.20% |
Total assets | 236.92M | -25.91% |
Total liabilities | 106.32M | 84.66% |
Total equity | 130.60M | — |
Shares outstanding | 98.51M | — |
Price to book | 7.12 | — |
Return on assets | -45.49% | — |
Return on capital | -57.26% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -67.26M | -391.56% |
Cash from operations | -29.57M | -71.99% |
Cash from investing | 15.41M | — |
Cash from financing | 749.00K | -98.92% |
Net change in cash | -13.43M | -125.76% |
Free cash flow | 3.28M | 116.22% |
About
Mind Medicine Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
Founded
2010
Website
Employees
74
